IGF1R and hepatocellular carcinoma: However, sorafenib-resistant HCC cells had higher expression levels of IGF-1R/p-IGF-1R, the stronger activity of stemness- and EMT-related properties, higher glycolytic enzymes, and greater mitochondria activity (Figure 6B).